Limitations of Data the Accredited Provider will ensure, to the extent possible, disclosure of limitations of data, e.g., ongoing research, interim analysis, or preliminary data.
Limitations of Data. The Peripheral Nerve Society will ensure, to the extent possible, meaningful disclosure of limitations on data (e.g., ongoing research, interim analysis, preliminary data, or unsupported opinions).
Limitations of Data. ASAM will ensure, to the extent possible, disclosure of limitations of data, eg, ongoing research, interim analyses, preliminary data, or unsupported opinion.
Limitations of Data. Recipient will ensure, to the extent possible, disclosure of limitations of data, e.g., ongoing research, interim analyses, preliminary data, or unsupported opinion.
Limitations of Data sponsor will ensure, to the extent possible, disclosure of limitations of data, e.g., ongoing research, interim analyses, preliminary data, or unsupported opinion.
Limitations of Data. Mississippi State Medical Association and St. Xxxxxxx’s will ensure, to the extent possible, disclosure of limitations of data, e.g. ongoing research, interim analyses, preliminary data, or unsupported opinion.
Limitations of Data. DUCOM will ensure, to the extent possible, disclosure of limitations of data, e.g., ongoing research, interim analyses, preliminary data, or unsupported opinion.
Limitations of Data. Speaker agrees to the extent possible, to disclosure of any limitations of data, e.g., ongoing research, interim analyses, preliminary data, or unsupported opinion.
Limitations of Data the provider and joint provider will ensure, to the extent possible, disclosure of limitations of data, e.g., ongoing research, interim analysis, preliminary data, or unsupported opinion. Discussion of Unapproved Uses: the provider and joint provider will require that presenters disclose when a product is not approved in the United States for the use under discussion. Opportunities for Debate: the provider and joint provider will ensure opportunities for questioning or scientific debate. Independence of Provider in the Use of Contributed Funds: Funds should be in the form of an educational grant made payable to the Pennsylvania Medical Society (PAMED may be substituted with joint provider’s name). All other support associated with this CME activity (e.g., distributing brochures, preparing slides) must be given with the full knowledge and approval of the accredited provider. No other funds from the commercial company will be paid to the program director, faculty, or others involved with the CME activity (additional honoraria, extra social events, etc.). The Commercial Supporter agrees to abide by all requirements of the ACCME Standards for Integrity and Independence in Continuing Medical Education. The Provider and Joint Provider agrees to 1) acknowledge educational support from the commercial company in activity brochures, syllabi, and other program materials, and 2) upon request, furnish the commercial supporter a report concerning the expenditure of the funds provided. Agreed Commercial Company Representative (name): Click or tap here to enter text. Signature: _____________________________________________________ Date: Click or tap here to enter text. Accredited CME Provider Representative (name): Click or tap here to enter text. Signature: _____________________________________________________ Date: Click or tap here to enter text. Joint-Provider Representative (name): Click or tap here to enter text. Please return the signed form to XXXXX’s CME department by email XXXXxxxx@xxxxxxxx.xxx, fax (000) 000-0000 or mail to Pennsylvania Medical Society, Attn: CME Dept., 000 Xxxxxxx Xxxxx Xxxx., Xxxxxxxxxxxxx, XX 00000. FOR PROVIDER USE ONLY Please indicate how commercial support was disclosed to the audience: ☐ Printed in the brochure or announcement of activity ☐ Announced verbally to audience during the activity ☐ Placed on flipchart or chalk board in front of audience ☐ Other (please specify) Click or tap here to enter text. Signature: ______________________...
Limitations of Data. Provider will ensure, to the extent possible, disclosure of any limitations of data, e.g., ongoing research, interim analyses, preliminary data, or unsupported opinion.
